Study: Misdiagnosis of lupus symptoms linked to mental health, trust issues
Patients whose autoimmune disorders such as lupus were initially dismissed by doctors as psychosomatic show long-lasting ...
Lupus Foundation of America11h
FDA Accepts Supplemental Biologics License Application for Gayzva for Treatment of Lupus Nephritis
The U.S. Food and Drug Administration (FDA) has accepted Genentech’s Supplemental Biologics License Application (sBLA) for ...
Le Lézard18h
FDA Accepts Supplemental Biologics License Application for Genentech's Gazyva for the Treatment of Lupus Nephritis
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has accepted the company's supplemental Biologics License ...
Daily16h
Medical Bulletin 05/ March/ 2025 - Video
Misdiagnosed Chronic Diseases can lead to long-Term Harm to Physical and Mental Health, Study revealsA ‘chasm of misunderstanding and miscommunication’ ...
Genentech gets FDA acceptance for its Lupus treatment's license application
Genentech, a Roche Group company(OTCQX:RHHBY) said on Wednesday that the U.S. FDA accepted the company’s supplemental ...
AARP11h
Is It Too Soon to Diagnose Alzheimer’s in People With No Symptoms?
Diagnosing Alzheimer's disease before people have any symptoms is possible, but brings up concerns when so few treatments are ...
BioSpace11h
Acelyrin Rejects Concentra’s Buyout Offer in Favor of Alumis Merger
Acelyrin and Alumis plan to close their merger in the second quarter of 2025, pending clearances and shareholder approval.